Restless Leg Syndrome/Willis-Ekbom Disease Pathophysiology.
Richard P Allen
Review
Sleep medicine clinics
2015
158 citations
PubMed
DOI
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'sleepcited.com';
const params = 'pmid\u003D26329430';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
Study Design
- Type d'étude
- Review
- Intervention
- Restless Leg Syndrome/Willis-Ekbom Disease Pathophysiology.
- Comparateur
- Placebo
- Direction de l'effet
- Neutral
- Risque de biais
- Unclear
Abstract
Restless leg syndrome/Willis-Ekbom disease has brain iron deficiency that produces excessive dopamine and known genetic risks, some of which contribute to the brain iron deficiency. Dopamine treatments work temporarily but may eventually produce further postsynaptic down-regulation and worse restless leg syndrome. This article includes sections focused on pathophysiologic findings from each of these areas: genetics, cortical-spinal excitability, and iron and dopamine.
Used In Evidence Reviews
Similar Papers
Sleep medicine · 2004
Dopamine and iron in the pathophysiology of restless legs syndrome (RLS).
392 citations
Neurology · 2004
Restless legs syndrome and pregnancy.
386 citations
Movement disorders : official journal of the Movement Disorder Society · 2008
Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice.
309 citations
Open Access
Nature reviews. Neurology · 2010
Restless legs syndrome: pathophysiology, clinical presentation and management.
293 citations
Sleep medicine · 2014
Altered brain iron homeostasis and dopaminergic function in Restless Legs Syndrome (Willis-Ekbom Disease).
281 citations
Sleep medicine · 2016
Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation.
280 citations
Open Access